Nomenclature of Eisenmenger Syndrome

Eisenmenger syndrome, stemming from congenital heart malformations, is characterized by systemic-to-pulmonary cardiovascular communication, pulmonary arterial disease, and cyanosis. This condition arises from left-to-right shunting due to an atrial septal defect (ASD) or ventral septal defect (VSD), leading to elevated pulmonary artery pressure and subsequent endothelial damage and hyperplasia in the lungs. Eventually, a right-to-left shunt develops, causing cyanosis. The term “Eisenmenger syndrome” emerged decades after its initial description, incorporating insights from various medical practitioners who contributed to classifying congenital heart conditions. Modern treatment guidelines aim to address underlying anatomical abnormalities contributing to pulmonary hypertension and shunting. Surgical interventions may include closure of septal defects, pulmonary artery banding, or systemic-to-pulmonary shunts. Patient suitability for surgery depends on factors such as pulmonary artery dilation and blood flow ratios. Advanced procedures such as heart-lung transplantation may be considered in select cases. Victor Eisenmenger’s significant contributions laid the groundwork for understanding congenital heart disorders. Despite not originating the term “Eisenmenger Syndrome,” his detailed descriptions led to its eponymous title. Eisenmenger’s work challenged prevailing beliefs on congenital heart disease and emphasized developmental origins. Maude Abbott, a pioneering female physician, made significant contributions to understanding congenital heart anomalies. Her work, including the Atlas of Congenital Cardiac Disease, described Eisenmenger syndrome and distinguished it from other conditions like Tetralogy of Fallot. Paul Wood, a renowned cardiologist, coined the term “Eisenmenger Syndrome” and expanded upon Eisenmenger’s work. He identified various heart conditions leading to Eisenmenger syndrome and elucidated its pathophysiology, emphasizing the role of pulmonary hypertension and shunting. Wood’s research highlighted the effectiveness of medications like acetylcholine and the protective effects of pulmonary artery stenosis in managing Eisenmenger syndrome. In summary, Eisenmenger syndrome represents a complex interplay of cardiovascular abnormalities with systemic implications. The contributions of Eisenmenger, Abbott, and Wood have been instrumental in understanding and managing this condition, paving the way for advancements in congenital heart disease treatment.